Garg Jay P, Elliott William J, Folker Amy, Izhar Munavvar, Black Henry R
Department of Preventive Medicine, RUSH University Medical Center, Chicago, Illinois, 60612, USA.
Am J Hypertens. 2005 May;18(5 Pt 1):619-26. doi: 10.1016/j.amjhyper.2004.11.021.
More than a decade ago, we found that a suboptimal medication regimen was the leading cause of resistant hypertension (RH) among patients referred to a tertiary care clinic. Since then, lower blood pressure (BP) goals have been recommended, suggesting that more patients may have RH. To assess whether the reasons for and treatment of RH have changed, we determined the frequency of various causes of resistance, the proportion of patients achieving goal BP, and the changes made in antihypertensive regimens.
The charts of all new patients seen at the RUSH University Hypertension Center between January 1, 1993, and November 1, 2001, were reviewed for strict criteria for RH: 1) physician referral for uncontrolled hypertension; 2) BP > or =140/90 mmHg despite use of three antihypertensive drugs; and 3) at least one follow-up visit. Patients were followed-up until goal BP was achieved on two consecutive visits or their last visit or until March 2002.
Of 1281 patients, 141 met criteria for RH. A cause of resistance was found in 94% of cases, including the following: drug-related causes (58%); nonadherence (16%); psychological causes (9%); office resistance (ie, in-clinic BP readings that were higher than goal despite treatment with antihypertensive medications and despite normotensive BP outside of the clinic as demonstrated by 24-h ambulatory BP monitoring) (6%); and secondary hypertension (5%). Overall, 53% of patients had their BP controlled to <140/90 mmHg, largely from regimen optimization and intensification, proper use of diuretics, and on average 4.1 +/- 1 antihypertensive medications (3.7 +/- 0.9 on referral).
These data are strikingly similar to those from our previous study of RH, in which a suboptimal medication regimen was the most common reason for resistance. Goal BP was most commonly achieved after optimizing the diuretic regimen and increasing the number of medications, suggesting that physicians should use these measures to attain the recommended lower BP goals If goal BP is not reached, referral to a clinical hypertension specialist may be appropriate.
十多年前,我们发现用药方案欠佳是三级护理诊所转诊患者中难治性高血压(RH)的主要原因。从那时起,建议采用更低的血压(BP)目标,这表明可能有更多患者患有RH。为了评估RH的病因和治疗是否发生了变化,我们确定了各种抵抗原因的频率、达到目标BP的患者比例以及抗高血压治疗方案的变化。
回顾了1993年1月1日至2001年11月1日期间在拉什大学高血压中心就诊的所有新患者的病历,以确定严格的RH标准:1)因高血压控制不佳由医生转诊;2)尽管使用了三种抗高血压药物,BP仍≥140/90 mmHg;3)至少有一次随访。对患者进行随访,直到连续两次就诊时达到目标BP或最后一次就诊,或直到2002年3月。
在1281例患者中,141例符合RH标准。94%的病例发现了抵抗原因,包括以下方面:药物相关原因(58%);不依从(16%);心理原因(9%);诊室抵抗(即尽管使用抗高血压药物治疗,但诊室血压读数高于目标值,而24小时动态血压监测显示诊所外血压正常)(6%);以及继发性高血压(5%)。总体而言,53%的患者血压控制在<140/90 mmHg,这主要得益于治疗方案的优化和强化、利尿剂的合理使用,平均使用4.1±1种抗高血压药物(转诊时为3.7±0.9种)。
这些数据与我们之前关于RH的研究结果惊人地相似,在之前的研究中,用药方案欠佳是抵抗的最常见原因。在优化利尿剂治疗方案并增加药物数量后,最常达到目标BP,这表明医生应采用这些措施来实现推荐的更低BP目标。如果未达到目标BP,转诊至临床高血压专家处可能是合适的。